Uquifa

Uquifa manufactures active pharmaceutical ingredients (APIs) and intermediates for the global pharmaceutical and animal health industries. It operates under cGMP conditions with regulatory approvals from major agencies. The company has over 85 years of experience and serves clients in more than 70 countries. It supports projects from proof-of-concept through to commercial manufacture for both generic and innovative companies[1][2][7].

No proprietary clinical results are reported as it does not develop its own drugs but manufactures for clients.

Over 50 active DMFs filed; more than 18 CEPs approved; portfolio includes over 150 APIs[1][5].

Recent strategic focus on digitization, capacity expansion, integrated project management across sites in Spain, Mexico, Hungary[7].